TR200002894T2 - L-Karnitin veya bir alkanoil L-Karnitin ve NADH ve/veya NADPH içeren kompozisyon - Google Patents
L-Karnitin veya bir alkanoil L-Karnitin ve NADH ve/veya NADPH içeren kompozisyonInfo
- Publication number
- TR200002894T2 TR200002894T2 TR2000/02894T TR200002894T TR200002894T2 TR 200002894 T2 TR200002894 T2 TR 200002894T2 TR 2000/02894 T TR2000/02894 T TR 2000/02894T TR 200002894 T TR200002894 T TR 200002894T TR 200002894 T2 TR200002894 T2 TR 200002894T2
- Authority
- TR
- Turkey
- Prior art keywords
- carnitine
- nadph
- alkanoyl
- composition containing
- containing nadh
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Psychology (AREA)
- Emergency Medicine (AREA)
- Nutrition Science (AREA)
- Molecular Biology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT98RM000238A IT1299161B1 (it) | 1998-04-17 | 1998-04-17 | Composizione comprendente l-carnitina o un'alcanoil l-carnitina e nadh e/o nadph |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200002894T2 true TR200002894T2 (tr) | 2001-01-22 |
Family
ID=11405812
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2000/02894T TR200002894T2 (tr) | 1998-04-17 | 1999-04-14 | L-Karnitin veya bir alkanoil L-Karnitin ve NADH ve/veya NADPH içeren kompozisyon |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP1071424A1 (hu) |
JP (1) | JP2002512191A (hu) |
KR (1) | KR20010042765A (hu) |
CN (1) | CN1299283A (hu) |
AU (1) | AU750645B2 (hu) |
BR (1) | BR9909712A (hu) |
CA (1) | CA2328331A1 (hu) |
EE (1) | EE200000601A (hu) |
HU (1) | HUP0101914A3 (hu) |
IL (1) | IL139014A0 (hu) |
IS (1) | IS5663A (hu) |
IT (1) | IT1299161B1 (hu) |
NO (1) | NO20005128L (hu) |
PL (1) | PL343482A1 (hu) |
SK (1) | SK15442000A3 (hu) |
TR (1) | TR200002894T2 (hu) |
WO (1) | WO1999053921A1 (hu) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8252309B2 (en) | 2000-04-04 | 2012-08-28 | Sigma-Tau Industrie Farmaceutiche Riunite Spa | Dietary supplement energy-providing to skeletal muscles |
DE10326822A1 (de) * | 2003-06-11 | 2005-01-05 | Herzpharma Vita-Check Diagnosegeräte GmbH | Mittel zur Nahrungsergänzung, dieses Mittel enthaltende pharmazeutische Präparate und Verwendungen des Mittels |
BRPI0721698A2 (pt) * | 2007-05-11 | 2013-01-22 | Sigma Tau Ind Famaceutiche Riunite S P A | gel étil para a liberaÇço de ingredientes ativos cosmÉticos |
AU2010286348A1 (en) * | 2009-08-31 | 2012-03-22 | University Of South Australia | Methods for diagnosis and treatment of chronic fatigue syndrome |
CN104306390A (zh) * | 2014-10-23 | 2015-01-28 | 苏州人本药业有限公司 | 还原型辅酶ⅱ的用途 |
CN104840479A (zh) * | 2015-02-17 | 2015-08-19 | 苏州人本药业有限公司 | Nadph在制备治疗心脏疾病药物中的应用 |
WO2019119445A1 (zh) * | 2017-12-22 | 2019-06-27 | 邦泰生物工程(深圳)有限公司 | 一种nadh复方组合物及其制剂和应用 |
CA3097412A1 (en) | 2018-04-20 | 2019-10-24 | Pacotrade Ag | Device for shredding of deep-frozen food products provided in block form |
CN109170907A (zh) * | 2018-08-30 | 2019-01-11 | 泓博元生命科技(深圳)有限公司 | 一种含有nmn的组合物、应用及运动饮料的制备方法 |
CN109105702A (zh) * | 2018-08-30 | 2019-01-01 | 泓博元生命科技(深圳)有限公司 | 一种含有nadh的组合物、应用及能量补充剂的制备方法 |
SG11202103646UA (en) * | 2018-10-10 | 2021-05-28 | So Ngor Sally Leung | Health-care product composition for enriching asthenic disease, preparation method therefor and use thereof |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1054698A (hu) * | 1964-12-04 | |||
US5292538A (en) * | 1992-07-22 | 1994-03-08 | Metagenics, Inc. | Improved sustained energy and anabolic composition and method of making |
DE4335454A1 (de) * | 1993-10-19 | 1995-04-20 | Schleicher Peter | Geriatrikum |
JPH09110708A (ja) * | 1995-08-11 | 1997-04-28 | Taisho Pharmaceut Co Ltd | 滋養強壮用生薬配合製剤 |
JPH0959161A (ja) * | 1995-08-23 | 1997-03-04 | Taisho Pharmaceut Co Ltd | 疲労改善用組成物 |
IT1277953B1 (it) * | 1995-12-21 | 1997-11-12 | Sigma Tau Ind Farmaceuti | Composizione farmaceutica contenente l-carnitina o una alcanoil l- carnitina e un acido poliinsaturo della serie 3-omega utile per |
IT1283951B1 (it) * | 1996-03-15 | 1998-05-07 | Mendes Srl | Uso della acetil l-carnitina o dei suoi sali farmacologicamente accettabili per il trattamento terapeutico o la profilassi di |
US5712259A (en) * | 1996-04-22 | 1998-01-27 | Birkmayer Pharmaceuticals | NADH and NADPH pharmaceuticals for treating chronic fatigue syndrome |
US6077828A (en) * | 1996-04-25 | 2000-06-20 | Abbott Laboratories | Method for the prevention and treatment of cachexia and anorexia |
JPH10175856A (ja) * | 1996-10-14 | 1998-06-30 | Taisho Pharmaceut Co Ltd | 疲労改善剤 |
-
1998
- 1998-04-17 IT IT98RM000238A patent/IT1299161B1/it active IP Right Grant
-
1999
- 1999-04-14 CN CN99805644A patent/CN1299283A/zh active Pending
- 1999-04-14 EE EEP200000601A patent/EE200000601A/xx unknown
- 1999-04-14 WO PCT/IT1999/000088 patent/WO1999053921A1/en not_active Application Discontinuation
- 1999-04-14 AU AU34428/99A patent/AU750645B2/en not_active Ceased
- 1999-04-14 HU HU0101914A patent/HUP0101914A3/hu unknown
- 1999-04-14 PL PL99343482A patent/PL343482A1/xx not_active Application Discontinuation
- 1999-04-14 BR BR9909712-5A patent/BR9909712A/pt not_active IP Right Cessation
- 1999-04-14 JP JP2000544325A patent/JP2002512191A/ja active Pending
- 1999-04-14 IL IL13901499A patent/IL139014A0/xx unknown
- 1999-04-14 SK SK1544-2000A patent/SK15442000A3/sk unknown
- 1999-04-14 TR TR2000/02894T patent/TR200002894T2/xx unknown
- 1999-04-14 EP EP99916039A patent/EP1071424A1/en not_active Withdrawn
- 1999-04-14 KR KR1020007011499A patent/KR20010042765A/ko not_active Application Discontinuation
- 1999-04-14 CA CA002328331A patent/CA2328331A1/en not_active Abandoned
-
2000
- 2000-10-12 NO NO20005128A patent/NO20005128L/no not_active Application Discontinuation
- 2000-10-13 IS IS5663A patent/IS5663A/is unknown
Also Published As
Publication number | Publication date |
---|---|
IT1299161B1 (it) | 2000-02-29 |
AU750645B2 (en) | 2002-07-25 |
HUP0101914A3 (en) | 2002-12-28 |
ITRM980238A0 (it) | 1998-04-17 |
IL139014A0 (en) | 2001-11-25 |
SK15442000A3 (sk) | 2001-06-11 |
BR9909712A (pt) | 2000-12-26 |
NO20005128D0 (no) | 2000-10-12 |
HUP0101914A2 (hu) | 2002-03-28 |
EE200000601A (et) | 2002-04-15 |
CA2328331A1 (en) | 1999-10-28 |
KR20010042765A (ko) | 2001-05-25 |
IS5663A (is) | 2000-10-13 |
AU3442899A (en) | 1999-11-08 |
NO20005128L (no) | 2000-12-18 |
ITRM980238A1 (it) | 1999-10-17 |
CN1299283A (zh) | 2001-06-13 |
JP2002512191A (ja) | 2002-04-23 |
EP1071424A1 (en) | 2001-01-31 |
PL343482A1 (en) | 2001-08-27 |
WO1999053921A1 (en) | 1999-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9714427A (pt) | Aparelho e método para medir não invasivamente a produção cardìaca | |
TR200002894T2 (tr) | L-Karnitin veya bir alkanoil L-Karnitin ve NADH ve/veya NADPH içeren kompozisyon | |
WO2003013549A3 (de) | Formulierung enthaltend (lyso-) phosphatidylserin zur vorbeugung und behandlung von stresszuständen bei warmblütern | |
BR0309855A (pt) | Pirazolpiridinas substituìdas com carbamato | |
BR9710585A (pt) | Composição para administração enteral, processo para melhorar a resistência fìsica ou desempenho atlético de um mamìfero, para aumentar a concentração de proteìna, massa corporal sem gordura ou massa muscular em um mamìfero, para diminuir a deposição de gordura corporal para uma dada ingestão calórica e aumentar a perda de gordura corporal em um mamìfero, para tratar os efeitos catabólicos de doença em um mamìfero, para aperfeiçoar a resistência fìsica ou o desempenho atléticode um mamìfero, e, para aumentar a massa de um corpo de carne magra de um mamìfero e diminuir a deposição de gordura | |
ZA9426B (en) | Use of riluzole for the treatment of Parkinson's Disease and Parkinsonian Syndromes | |
MX9402938A (es) | Composicion terapeutica que comprende nicotinamida-adenina-dinucleotido ynicotinamida-adenina-fosfato-dinucleotido, estable ingerible y absorbible. | |
CY1108629T1 (el) | Συνδυασμος ετ 743 με 5 φθοριοουρακιλο προ-φαρμακα δια την θεραπευτικη αγωγη του καρκικου | |
PT1163904E (pt) | Composicao para a prevencao de doencas do musculo liso, compreendendo ascorbato, arginina e magnesio | |
CA2377128A1 (en) | Composition for the prevention of muscle fatigue and skeletal muscle adaptation to strenuous exercise | |
ATE366106T1 (de) | Zusammensetzung für die pharmazeutische oder dietätische verwendung zur bekämpfung von haarausfall | |
HUP9700806A2 (hu) | Tianeptin-nátriumsó nyújtott felszabadulását biztosító, szájon át beadható mátrix tabletta és eljárás előállítására | |
PE20001325A1 (es) | Combinacion de cerivastatina y fibratos | |
GR900300043T1 (en) | Use of the enzyme-cofactor nadph in the preparation of a pharmaceutical, pharmaceutical and preparation thereof | |
IT1295408B1 (it) | Associazione di l-carnitina e alcanoil l-carnitine per il trattamento dell'alcoolismo | |
BRPI0409699A (pt) | métodos de indução do efeito diurético, de indução, manutenção ou restauração do efeito diurético de diurético não modificador de adenosina, de manutenção, restauração ou melhoria da função renal em paciente, de indução de diurese, de prevenção do inìcio de deficiência renal em paciente com sobrecarga de fluidos ou chf, de tratamento de paciente que sofre de chf e de melhoria dos resultados globais da saúde, composição farmacêutica e seus usos | |
MX9703810A (es) | Medicamento que comprende un derivado de carnitinapara tratar la enfermedad de alzheimer en pacientes con inicio prematuro. | |
EP1393738A4 (en) | MEDICINE AGAINST DIABETES | |
BR0108261A (pt) | Uso de mirtazapina, método de tratamento de um distúrbio do sono em um indivìduo, e, kit para paciente para o tratamento de distúrbios do sono | |
CA2059510A1 (en) | Use of nadh and nadph as energy substitutes | |
Ott et al. | Functional knee braces | |
HUP9701606A2 (hu) | Szulbutiamin alkalmazása bizonyos pszichomotoros és pszichointellektuális rendellenességek kezelésére használható gyógyszerkészítmények előállítására | |
CA2304899A1 (en) | New use of selective serotonin reuptake inhibitors for treatment of human patients with chest pain of non-cardiac origin or with gastro-esophageal reflux disease | |
BR0303384A (pt) | Citalopram e seus usos no tratamento de pressão sanguìnea elevada | |
UA41652A (uk) | Спосіб лікування хворих на гіпертонічну хворобу |